Results 251 to 260 of about 2,437,403 (392)
Low dose tezosentan, an intravenous dual endothelin receptor antagonist, decreases type B-natruretic peptide levels in patients with acute decompensated heart failure [PDF]
Guillermo Torre‐Amione +13 more
openalex +1 more source
The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension
ABSTRACT Background Treprostinil for the treatment of bronchopulmonary dysplasia‐associated pulmonary hypertension (BPD‐PH) has previously been described in small cohort studies, often used later in the course after failure to improve on other therapies.
Stephanie M. Tsoi +8 more
wiley +1 more source
Endothelin 1 (EDN1; ET1); endothelin receptor [PDF]
openaire +1 more source
Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting. [PDF]
Speck D +6 more
europepmc +1 more source
ABSTRACT There is a limited understanding of how pulmonary hypertension (PH) patients are managed worldwide. The Pulmonary Vascular Research Institute (PVRI) Innovative Drug Discovery Initiative (IDDI) global survey attempted to obtain insights into access to PH care in diverse international regions to pave future action plans.
Sasha Z. Prisco +9 more
wiley +1 more source
Endothelin 1 (EDN1; ET1); endothelin receptor [PDF]
openaire +1 more source
Protective Effects of Bosentan via Endothelin Receptor Antagonism in Experimental Ischemia-Reperfusion Injury in the Lower Limb of Rats. [PDF]
Demirtaş H +9 more
europepmc +1 more source

